Kennedy Chibesa

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 9

Top Topics

Escherichia Coli

Antimicrobial Resistance

Irritable Bowel Syndrome

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Kapambwe Mwape, Cynthia Mubanga, Obvious Nchimunya Chilyabanyama, Kennedy Chibesa, Caroline Cleopatra Chisenga, Suwilanji Silwamba, Arlo Randall, Xiaowu Liang, Tobias George Barnard, Michelo Simuyandi, Roma Chilengi
Application of a Novel Proteomic Microarray Reveals High Exposure to Diarrhoeagenic Escherichia coli among Children in Zambia Participating in a Phase I Clinical Trial. Microorganisms 12 (3) (2024)
Caroline Cleopatra Chisenga, Bernard Phiri, Harriet Ng'ombe, Mutinta Muchimba, Kalo Musukuma-Chifulo, Suwilanji Silwamba, Natasha Makabilo Laban, Chaluma Luchen, Fraser Liswaniso, Kennedy Chibesa, Cynthia Mubanga, Kapambwe Mwape, Michelo Simuyandi, Adam F Cunningham, David Sack, Samuel Bosomprah
Seroconversion and Kinetics of Vibriocidal Antibodies during the First 90 Days of Re-Vaccination with Oral Cholera Vaccine in an Endemic Population. Vaccines 12 (4) (2024)
Nsofwa Sukwa, Samuel Bosomprah, Paul Somwe, Monde Muyoyeta, Kapambwe Mwape, Kennedy Chibesa, Charlie Chaluma Luchen, Suwilanji Silwamba, Bavin Mulenga, Masiliso Munyinda, Seke G Y Muzazu, Masuzyo Chirwa-Chobe, Mwelwa Chibuye, Michelo Simuyandi, Roma Chilengi, Ann-Mari Svennerholm
The Incidence and Risk Factors for Enterotoxigenic E. coli Diarrheal Disease in Children under Three Years Old in Lusaka, Zambia. Microorganisms 12 (4) (2024)
Caroline Cleopatra Chisenga, Bernard Phiri, Harriet Ng'ombe, Mutinta Muchimba, Kalo Musukuma-Chifulo, Suwilanji Silwamba, Natasha Makabilo Laban, Chaluma Luchen, Fraser Liswaniso, Kennedy Chibesa, Cynthia Mubanga, Kapambwe Mwape, Michelo Simuyandi, Adam F Cunningham, David Sack, Samuel Bosomprah
Seroconversion and Kinetics of Vibriocidal Antibodies during the First 90 Days of Re-Vaccination with Oral Cholera Vaccine in an Endemic Population. Vaccines 12 (4) (2024)
Kapambwe Mwape, Cynthia Mubanga, Obvious Nchimunya Chilyabanyama, Kennedy Chibesa, Caroline Cleopatra Chisenga, Suwilanji Silwamba, Arlo Randall, Xiaowu Liang, Tobias George Barnard, Michelo Simuyandi, Roma Chilengi
Application of a Novel Proteomic Microarray Reveals High Exposure to Diarrhoeagenic Escherichia coli among Children in Zambia Participating in a Phase I Clinical Trial. Microorganisms 12 (3) (2024)
Nsofwa Sukwa, Samuel Bosomprah, Paul Somwe, Monde Muyoyeta, Kapambwe Mwape, Kennedy Chibesa, Charlie Chaluma Luchen, Suwilanji Silwamba, Bavin Mulenga, Masiliso Munyinda, Seke G Y Muzazu, Masuzyo Chirwa-Chobe, Mwelwa Chibuye, Michelo Simuyandi, Roma Chilengi, Ann-Mari Svennerholm
The Incidence and Risk Factors for Enterotoxigenic E. coli Diarrheal Disease in Children under Three Years Old in Lusaka, Zambia. Microorganisms 12 (4) (2024)
Innocent Mwape, Natasha Makabilo Laban, Kennedy Chibesa, Andrew Moono, Suwilanji Silwamba, Moffat Mulemena Malisheni, Caroline Chisenga, Adriace Chauwa, Paul Simusika, Mabvuto Phiri, Michelo Simuyandi, Roma Chilengi, Corena De Beer, David Ojok
Characterization of Rotavirus Strains Responsible for Breakthrough Diarrheal Diseases among Zambian Children Using Whole Genome Sequencing. Vaccines 11 (12) (2023)
Kapambwe Mwape, Samuel Bosomprah, Kennedy Chibesa, Suwilanji Silwamba, Charlie Chaluma Luchen, Nsofwa Sukwa, Cynthia Mubanga, Bernard Phiri, Mwelwa Chibuye, Fraser Liswaniso, Paul Somwe, Obvious Nchimunya Chilyabanyama, Caroline Cleopatra Chisenga, Monde Muyoyeta, Michelo Simuyandi, Tobias George Barnard, Roma Chilengi
Prevalence of Diarrhoeagenic Escherichia coli among Children Aged between 0-36 Months in Peri-Urban Areas of Lusaka. Microorganisms 11 (11) (2023)
Innocent Mwape, Natasha Makabilo Laban, Kennedy Chibesa, Andrew Moono, Suwilanji Silwamba, Moffat Mulemena Malisheni, Caroline Chisenga, Adriace Chauwa, Paul Simusika, Mabvuto Phiri, Michelo Simuyandi, Roma Chilengi, Corena De Beer, David Ojok
Characterization of Rotavirus Strains Responsible for Breakthrough Diarrheal Diseases among Zambian Children Using Whole Genome Sequencing. Vaccines 11 (12) (2023)